Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight ; volume:18 ; number:1 ; day:11 ; month:11 ; year:2020 ; pages:1-13 ; date:12.2020
Journal of translational medicine ; 18, Heft 1 (11.11.2020), 1-13, 12.2020
- Creator
-
Land, Craig A.
Musich, Phillip R.
Haydar, Dalia
Krenciute, Giedre
Xie, Qian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-020-02598-0
- URN
-
urn:nbn:de:101:1-2020122219371416996288
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Land, Craig A.
- Musich, Phillip R.
- Haydar, Dalia
- Krenciute, Giedre
- Xie, Qian
- SpringerLink (Online service)
Other Objects (12)
Chimeric Antigen Receptor T-Cell Therapy
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Chimeric Antigen Receptor T-Cell Therapy
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma
Chimeric antigen receptor T-cell therapy for relapsed and refractory thyroid cancer
Chimeric Antigen Receptor T-Cell Therapy
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Chimeric antigen receptor T‑cell therapy—a hematological success story
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma